Biotech

All Articles

2 cancer cells biotechs combine, producing global footprint

.OncoC4 is taking AcroImmune-- as well as its own in-house medical manufacturing functionalities-- u...

Amgen records very first period 3 win for $400M dermatitis medicine

.Amgen has discussed (PDF) the initial phase 3 data on its own $400 million eczema drug, connecting ...

Biogen, UCB file stage 3 lupus gain after falling short earlier trial

.Biogen as well as UCB's bet one's bottom dollar improving in to phase 3 on the back of a broken stu...

Aptadir wishes new RNA preventions can easily reverse challenging cancers

.Italian biotech Aptadir Rehabs has actually introduced along with the assurance that its own pipeli...

Wave surfs DMD excellence to regulators' doors, sending stock up

.Wave Lifestyle Sciences has actually fulfilled its own objective in a Duchenne muscular dystrophy (...

Sanofi picks brand new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma crease, usi...

Achilles droplets tissue treatment plan, supports for discharges after missing 'office practicality' objectives

.Achilles Therapeutics has actually torn up its own technique. The English biotech is actually knock...

Aligos heralds period 2 MASH win, lowering liver body fat as much as 46%

.Aligos Therapeutics is heralding a midstage gain in metabolic-dysfunction connected steatohepatitis...

Basilea credit ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job establishing brand new antifungals has received a notable boost from th...

Capricor offers Europe liberties to late-stage DMD therapy for $35M

.Possessing actually gathered up the U.S. civil liberties to Capricor Therapeutics' late-stage Duche...